TrialThe oncologist2020

Cladribine with Granulocyte Colony-Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study.

Hua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.